Clinical Trial Update: The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating tolerability and adherence of dolutegravir combined with fixed-dose emtricitabine/tenofovir disoproxil fumarate for non-occupati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
• Tivicay (dolutegravir)

Snippet

Sponsor: Andrew Carr | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED